COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 21:05

– Company plans to initiate registration-directed trial of tipifarnib in second half of 2018 following recent end of Phase 2 meeting with the FDA – – Single-arm trial to enroll at least 59 recurrent or metastatic HRAS [...]

Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments

12/03/2018 - 21:05

Company Remains on Target for Full Year Revenue of $50.0 - $55.0 Million Intensified Business Development Effort Results in New Customer Contract and Strengthened Backlog TUSTIN, Calif., March 12, 2018 (GLOBE NEWSWIRE [...]

Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating Results

12/03/2018 - 21:05

2017 Revenue of $134.5 million, growth of 43%; 4Q 2017 Revenue of $43.9 million, growth of 61% Provides initial 2018 financial outlook MOORESTOWN, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“ [...]

Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo

12/03/2018 - 21:05

CAMBRIDGE, Mass. and CARLSBAD, Calif. , March 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), and Ionis Pharmaceuticals, Inc., today [...]

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 21:01

-- Continuing Enrollment in Pivotal Phase 3 Clinical Trial of Setmelanotide in Pro-Opiomelanocortin (POMC) Deficiency Obesity; On Track to Complete Enrollment of 10 Patients in First Half of 2018 -- -- Enrolled First [...]

Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

12/03/2018 - 21:01

SAN CARLOS, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market

12/03/2018 - 18:38

SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced that members of its Board of Directors recently [...]

IntelGenx Clarifies Recent Preliminary 2018 Proxy Statement Filing

12/03/2018 - 18:12

SAINT LAURENT, Quebec, March 12, 2018 (GLOBE NEWSWIRE) -- In response to investor inquiries received about its preliminary proxy statement, filed with the U.S. Securities and Exchange Commission on March 7, 2018, [...]

Kiadis Pharma N. V.: CORRECTION (Includes Disclaimers) Kiadis Pharma launches a private placement of approximately 2.6 million new shares

12/03/2018 - 17:58

Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]

Kiadis Pharma N. V.: Kiadis Pharma launches a private placement of approximately 2.6 million new shares

12/03/2018 - 17:46

Kiadis Pharma launches a private placement of approximately 2.6 million new shares Amsterdam, The Netherlands, March 12, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]

Annual General Meeting in ALK-Abelló A/S held on 12 March 2018

12/03/2018 - 17:22

Copenhagen, 2018-03-12 17:22 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 12 March 2018. The annual general meeting transacted the following business: Adoption [...]

Portola Pharmaceuticals Announces New Interim Results from Ongoing ANNEXA-4 Study of Factor Xa Inhibitor Reversal Agent AndexXa® (Andexanet Alfa) in Patients with Life-Threatening Bleeding

12/03/2018 - 17:12

– Excellent or Good Hemostasis Achieved in 83 Percent of Patients; Thrombotic Events Consistent with High Background Thrombotic Risk – – Data Presented in Late-Breaking Clinical Trial Session at American College of [...]

UPDATE -- Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County

12/03/2018 - 17:05

MIAMI, March 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County. [...]

Ossur Hf : Transactions in relation to share buyback program

12/03/2018 - 17:01

Announcement no. 20/2018 Reykjavik, 12 March 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

Shire plc : Elections for the interim dividend in respect of the six months to December 31, 2017

12/03/2018 - 16:31

Elections for the interim dividend in respect of the six months to December 31, 2017 March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announced on February 14, 2018, an interim dividend of 29.79 US [...]

Shire plc : Director/PDMR Shareholding

12/03/2018 - 16:30

Director/PDMR Shareholding March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Orphazyme Annual Report 2017 Presentation

12/03/2018 - 16:23

Orphazyme A/S Investor news No. 05/2018 Copenhagen, March 12, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the [...]

Progressive Care CEO, S. Parikh Mars, Joins Everett Jolly on Uptick Newswire's "Stock Day" Podcast

12/03/2018 - 16:11

Phoenix, March 12, 2018 (GLOBE NEWSWIRE) -- Phoenix, AZ – March 13, 2018 – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a healthcare services and technology company, joins Uptick Newswire to discuss recent [...]

Medifirst Solutions Announces an Update for China Distribution

12/03/2018 - 15:54

FREEHOLD, NJ, March 12, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]